{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:04:21Z","timestamp":1789470261779,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective transition from pediatric to adult care is essential in Duchenne muscular dystrophy (DMD), but evidence on how transition is delivered in everyday practice remains limited. In Turkey, no clinical framework specifies how transition should occur, although national regulation requires completion of transfer by age 23. This study aimed to describe current practice, identify barriers and facilitators from physician and patient perspectives, and compare findings with international frameworks to inform a national guideline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>As part of the AIM-DMD (National plan of action to raise Awareness and Improve Medical care of Duchenne Muscular Dystrophy) initiative, we conducted a national cross-sectional survey between June and December 2025, comprising parallel sub-studies of physicians and patients with DMD and their caregivers. Two structured online questionnaires were developed, guided by the Got Transition Six Core Elements framework and international Delphi consensus statements. The physician survey was distributed through professional networks; the patient and caregiver survey through the DMD Families Association and neuromuscular reference centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-two physicians (43 pediatric and 19 adult neurologists) from 28 cities and 48 patients and caregivers from 24 of these cities responded. Only 17.7% of physicians reported a systematic institutional transition program, 38.7% prepared individualized transition plans, and 9.7% described true readiness assessment. Joint pretransition consultations were held regularly by only 6.5% of physicians. Among transitioned patients, 72.4% first heard about transition at age 17 or later, and 62.1% considered their preparation inadequate. All physicians reported transferring medical data at transition, most commonly through institutional electronic health records (80.6%); however, 41.4% of patients and caregivers were unaware that any information had been conveyed to the adult team. Physicians, patients, and caregivers all identified the lack of a formal transition protocol, joint pediatric and adult consultations, multidisciplinary integration, and a designated coordinator role as priority areas for improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DMD transition care across Turkey lacks consistent structure. Key gaps include limited readiness assessment, delayed discussions, poor patient and caregiver awareness of the transition process, and lack of coordinated multidisciplinary structures. Our study identified common priorities raised by physicians, patients, and caregivers that need to be improved and could inform the development of standardized protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04454-8","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:06:19Z","timestamp":1782144379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transition from pediatric to adult neurology care in Duchenne muscular dystrophy: a national survey of patient and physician experiences"],"prefix":"10.1186","volume":"21","author":[{"given":"Gulcin","family":"Akinci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eray","family":"Ontas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Topaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"4","key":"4454_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1054-139X(03)00208-8","volume":"33","author":"DS Rosen","year":"2003","unstructured":"Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM, Society for Adolescent Medicine. Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health. 2003;33(4):309\u201311. https:\/\/doi.org\/10.1016\/S1054-139X(03)00208-8.","journal-title":"J Adolesc Health"},{"issue":"5","key":"4454_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/mus.25725","volume":"56","author":"S Paganoni","year":"2017","unstructured":"Paganoni S, Nicholson K, Leigh F, Swoboda K, Chad D, Drake K, et al. Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve. 2017;56(5):848\u201358. https:\/\/doi.org\/10.1002\/mus.25725.","journal-title":"Muscle Nerve"},{"key":"4454_CR3","doi-asserted-by":"publisher","unstructured":"White PH, Cooley WC, Transitions Clinical Report Authoring Group, American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2018;142(5). https:\/\/doi.org\/10.1542\/peds.2018-2587.","DOI":"10.1542\/peds.2018-2587"},{"issue":"6","key":"4454_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41390-021-01396-8","volume":"90","author":"SW Jarvis","year":"2021","unstructured":"Jarvis SW, Roberts D, Flemming K, Richardson G, Fraser LK. Transition of children with life-limiting conditions to adult care and healthcare use: a systematic review. Pediatr Res. 2021;90(6):1120\u201331. https:\/\/doi.org\/10.1038\/s41390-021-01396-8.","journal-title":"Pediatr Res"},{"key":"4454_CR5","doi-asserted-by":"publisher","unstructured":"Trout CJ, Case LE, Clemens PR, McArthur A, Noritz G, Ritzo M, et al. A transition toolkit for Duchenne muscular dystrophy. Pediatrics. 2018;142(Suppl 2):SS110\u201317. https:\/\/doi.org\/10.1542\/peds.2018-0333M.","DOI":"10.1542\/peds.2018-0333M"},{"issue":"1","key":"4454_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13023-025-04144-x","volume":"21","author":"T Evangelista","year":"2025","unstructured":"Evangelista T, Ali H, Handberg C, Sejersen T, Quinlivan R, Moroni I, et al. Transition from childhood to adulthood in neuromuscular disorders: results from the ERN EURO-NMD survey. Orphanet J Rare Dis. 2025;21(1):15. https:\/\/doi.org\/10.1186\/s13023-025-04144-x.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4454_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s13023-025-03973-0","volume":"20","author":"LL Tosi","year":"2025","unstructured":"Tosi LL, Hart TS, Beug G, Carter E, Perfetto EM. Somewhere to go: a position paper on addressing gaps in transition care for adults with childhood-onset rare diseases. Orphanet J Rare Dis. 2025;20(1):498. https:\/\/doi.org\/10.1186\/s13023-025-03973-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"4454_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251\u201367. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3.","journal-title":"The Lancet Neurol"},{"issue":"7","key":"4454_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","volume":"35","author":"E Landfeldt","year":"2020","unstructured":"Landfeldt E, Thompson R, Sejersen T, McMillan HJ, Kirschner J, Lochmuller H. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(7):643\u201353. https:\/\/doi.org\/10.1007\/s10654-020-00613-8.","journal-title":"Eur J Epidemiol"},{"key":"4454_CR10","doi-asserted-by":"publisher","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;2016(6):CD003725. https:\/\/doi.org\/10.1002\/14651858.CD003725.pub4.","DOI":"10.1002\/14651858.CD003725.pub4"},{"issue":"5","key":"4454_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Colvin MK, et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17(5):445\u201355. https:\/\/doi.org\/10.1016\/S1474-4422(18)30026-7.","journal-title":"The Lancet Neurol"},{"issue":"4","key":"4454_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mus.28468","volume":"72","author":"C Wozow","year":"2025","unstructured":"Wozow C, Mosher K. Transitions from pediatric to adult neuromuscular care: a practical guide. Muscle Nerve. 2025;72(4):558\u201365. https:\/\/doi.org\/10.1002\/mus.28468.","journal-title":"Muscle Nerve"},{"key":"4454_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejpn.2025.01.004","volume":"54","author":"D Castro","year":"2025","unstructured":"Castro D, Sejersen T, Bello L, Buccella F, Cairns A, Carranza-Del Rio J, et al. Transition of patients with Duchenne muscular dystrophy from paediatric to adult care: an international Delphi consensus study. Eur J Paediatr Neurol. 2025;54:130\u201339. https:\/\/doi.org\/10.1016\/j.ejpn.2025.01.004.","journal-title":"Eur J Paediatric Neurol"},{"issue":"1","key":"4454_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.dhjo.2016.10.002","volume":"10","author":"S Lindsay","year":"2017","unstructured":"Lindsay S, McAdam L, Mahendiran T. Enablers and barriers of men with Duchenne muscular dystrophy transitioning from an adult clinic within a pediatric hospital. Disabil Health J. 2017;10(1):73\u201379. https:\/\/doi.org\/10.1016\/j.dhjo.2016.10.002.","journal-title":"Disabil Health J"},{"issue":"1","key":"4454_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s42466-022-00206-8","volume":"4","author":"M Fleischer","year":"2022","unstructured":"Fleischer M, Coskun B, Stolte B, Della-Marina A, Kolbel H, Lax H, et al. Essen transition model for neuromuscular diseases. Neurol Res Pract. 2022;4(1):41. https:\/\/doi.org\/10.1186\/s42466-022-00206-8.","journal-title":"Neurol Res Pract"},{"key":"4454_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pedn.2020.01.002","volume":"51","author":"A Schmidt","year":"2020","unstructured":"Schmidt A, Ilango SM, McManus MA, Rogers KK, White PH. Outcomes of pediatric to adult Health care transition interventions: an updated systematic review. J Pediatr Nurs. 2020;51:92\u2013107. https:\/\/doi.org\/10.1016\/j.pedn.2020.01.002.","journal-title":"J Educ Chang Pediatr Nurs"},{"key":"4454_CR17","doi-asserted-by":"publisher","unstructured":"Paramsothy P, Herron AR, Lamb MM, Kinnett K, Wolff J, Yang ML, et al. Health care transition experiences of males with childhood-onset Duchenne and Becker muscular dystrophy: findings from the muscular dystrophy surveillance tracking and Research Network (MD STARnet) health care transitions and other life experiences survey. PLoS Curr. 2018;10. https:\/\/doi.org\/10.1371\/currents.md.7de8a1c6798d7a48d38ea09bd624e1cd.","DOI":"10.1371\/currents.md.7de8a1c6798d7a48d38ea09bd624e1cd"},{"issue":"3","key":"4454_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.36185\/2532-1900-447","volume":"43","author":"C Spagnoli","year":"2024","unstructured":"Spagnoli C, Adorisio R, Bello L, D\u2019Amico A, D\u2019Angelo MG, Pane M, et al. Transition and management of patients with Duchenne muscular dystrophy: a narrative review based on Italian experts\u2019 opinion and real-world experience. Acta Myol. 2024;43(3):102\u201307. https:\/\/doi.org\/10.36185\/2532-1900-447.","journal-title":"Acta Myol"},{"issue":"1","key":"4454_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13023-024-03270-2","volume":"19","author":"MJ Molnar","year":"2024","unstructured":"Molnar MJ, Szabo L, Vladacenco OA, Cobzaru AM, Dor T, Dori A, et al. Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel. Orphanet J Rare Dis. 2024;19(1):260. https:\/\/doi.org\/10.1186\/s13023-024-03270-2.","journal-title":"Orphanet J Rare Dis"},{"key":"4454_CR20","doi-asserted-by":"publisher","unstructured":"American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002;110(6 Pt 2):1304\u201306. https:\/\/doi.org\/10.1542\/peds.110.S3.1304.","DOI":"10.1542\/peds.110.S3.1304"},{"key":"4454_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pediatrneurol.2025.10.006","volume":"174","author":"A Marcassoli","year":"2026","unstructured":"Marcassoli A, Rajapakse N, Guastafierro E, Petropoulos JA, Trucco G, Mazzilli A, et al. Gaps and challenges in the transition of care in neuromuscular disorders with a focus on Duchenne muscular dystrophy. Pediatr Neurol. 2026;174:74\u201380. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2025.10.006.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"4454_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/children10060959","volume":"10","author":"M Lupu","year":"2023","unstructured":"Lupu M, Ioghen M, Perjoc R-\u0218, Scarlat AM, Vladacenco OA, Roza E, et al. The importance of implementing a transition strategy for patients with muscular dystrophy: from child to adult\u2014insights from a tertiary centre for rare neurological diseases. Children (Basel). 2023;10(6):959. https:\/\/doi.org\/10.3390\/children10060959.","journal-title":"Children (Basel)"},{"issue":"3","key":"4454_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10072-023-07101-3","volume":"45","author":"L Nanetti","year":"2024","unstructured":"Nanetti L, Kearney M, Boesch S, Stovickova L, Ortigoza-Escobar JD, Macaya A, et al. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND). Neurol Sci. 2024;45(3):1007\u201316. https:\/\/doi.org\/10.1007\/s10072-023-07101-3.","journal-title":"Neurol. Sci"},{"issue":"2","key":"4454_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/jpepsy\/jsp128","volume":"36","author":"GS Sawicki","year":"2011","unstructured":"Sawicki GS, Lukens-Bull K, Yin X, Demars N, Huang IC, Livingood W, et al. Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ\u2014transition readiness assessment questionnaire. J Pediatr Psychol. 2011;36(2):160\u201371. https:\/\/doi.org\/10.1093\/jpepsy\/jsp128.","journal-title":"J Pediatr Psychol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04454-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04454-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:21:43Z","timestamp":1789467703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04454-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4454"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04454-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ankara University Faculty of Medicine Human Research Ethics Committee on 24 June 2025 (approval number 2025\/481). The study was conducted in accordance with the Declaration of Helsinki. Both surveys were conducted anonymously. Electronic informed consent was obtained from all participants prior to survey completion. For physicians, caregivers, and adult patients (aged 18\u2009years or older), consent was obtained directly from the respondent. For patients under 18\u2009years of age, consent was provided by a parent or caregiver. Participants were informed at the time of consent that anonymized responses, including open-ended comments, could be used in publications. No individually identifiable data are presented.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"318"}}